Aminoguanidine ameliorates overexpression of prosclerotic growth factors and collagen deposition in experimental diabetic nephropathy

Journal of the American Society of Nephrology

Volumn 12, Issue 10, 2001, Pages 2098-2107

  Kelly, D J ^a   Gilbert, R E ^a   Cox, A J ^a   Soulis, T ^a   Jerums, G ^a   Cooper, M E ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; AMINOGUANIDINE; COLLAGEN; COLLAGEN TYPE 4; CYTOKINE; DRINKING WATER; GROWTH FACTOR; MESSENGER RNA; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA1;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXPERIMENTAL MODEL; IN SITU HYBRIDIZATION; KIDNEY INTERSTITIUM; KIDNEY TUBULE; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT; STREPTOZOCIN DIABETES;

EID: 0034823675     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/asn.v12102098     Document Type: Article

References (49)

1. The tubulointerstitium in progressive renal disease
2. Structural-functional relationship in diabetic nephropathy
3. Expression of transforming growth factor-beta and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition
4. Basement membrane abnormalities in diabetes mellitus: Relationship to clinical microangiopathy
5. Renal tubular basement membrane and collagen type IV in diabetes mellitus
6. Transforming growth factor beta in tissue fibrosis
7. Role of platelet-derived growth factor in glomerular disease
8. ANG II is a mitogen for a murine cell line isolated from medullary thick ascending limb of Henle's loop
9. Elevated glucose stimulates TGF-b gene expression and bioactivity in proximal tubule
10. High glucose induces cell hypertrophy and stimulates collagen gene transcription in proximal tubule
11. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia
12. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications
13. Receptor-specific increase in extracellular matrix production in mouse mesangial cells by advanced glycation end products is mediated via platelet-derived growth factor
14. PDGF and TGF-beta mediate collagen production by mesangial cells exposed to advanced glycosylation end products
15. Triphasic changes in selectivity with increasing proteinuria in type I and type II diabetes
16. Interlaboratory variation in GHb assays in Victoria, Australia
17. SPARC gene expression is reduced in early diabetes related kidney growth
18. Towards quantitative in situ hybridization
19. Transforming growth factor-β in diabetic nephropathy
20. 33P
21. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
22. Localization of angiotensin II receptors in rat and monkey kidney by in vitro autoradiography
23. Vascular endothelial growth factor and its receptors in control and diabetic rat eyes
24. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury
25. Application of photoshop-based image analysis to quantification of hormone receptor expression in breast cancer
26. Protein glycation in the kidney - Role in diabetes and aging
27. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats
28. Retardation by aminoguanidine of development of albuminuria, mesangial expansion, and tissue fluorescence in streptozocin-induced diabetic rat
29. The effects of aminoguanidine in preventing experimental diabetic nephropathy are related to duration of treatment
30. Expression of transforming growth factor-Β1 and type IV collagen in the renal tubulointerstitium in experimental diabetes: Effects of angiotensin converting enzyme inhibition
31. The tubulointerstitium in progressive diabetic kidney disease: More than an aftermath of glomerular injury?
32. Effect of diabetes and aminoguanidine therapy on renal advanced glycation endproduct binding
33. Immunocytochemical detection of advanced glycated end products in rat renal tissue as a function of age and diabetes
34. Prevention of diabetic nephropathy in db/db mice with glycated albumin antagonists
35. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator
36. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease
37. AGE modified BSA enhances TGF-β expression and bioactivity in LLC-PK1 cells in a protease sensitive manner
38. Advanced glycation endproducts stimulate the MAP-kinase pathway in tubulus cell line LLC-PK1
39. Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease
40. Vascular hypertrophy in experimental diabetes: Role of advanced glycation end products
41. mRNA expression of growth factors in glomeruli from diabetic rats
42. TGF-beta induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop
43. Fibrogenic cytokines and connective tissue production
44. Infusion of PDGF or basic FGF induces selective glomerular mesangial cell proliferation and matrix accumulation in rats
45. Prevention of diabetic vascular dysfunction by guanidines. Inhibition of nitric oxide synthase versus advanced glycation end-product formation
46. Aminoguanidine, a novel inhibitor of nitric oxide fomation, prevents diabetic vascular dysfunction
47. Regulation of transforming growth factor betal by nitric oxide
48. Endothelin ET(A) receptor antagonist reverses the inhibitory effect of platelet-derived growth factor on cytokineinduced nitric oxide production
49. Renoprotective effects of a novel inhibitor of advanced glycation